文献速递肝病消化道肿瘤与早癌

Erbin 表达升高使 ERα 蛋白不稳定并促进肝细胞癌发生

Elevated expression of Erbin destabilizes ERα protein and promotes tumorigenesis in hepatocellular carcinoma.
PubMed 文献 · J Hepatol · 2017-02-10

研究通过免疫组化检测人肝细胞癌(HCC)样本中 Erbin 与 ERα 表达,并结合体外、体内实验及 DEN 或 DEN/CCl4 诱导的 Erbin+/+ 与 ErbinΔC/ΔC 小鼠模型,发现 Erbin 经与 ERα 相互作用增强 Chip 与 ERα 结合、促进 ERα 泛素化降解,从而灭活 ERα 信号驱动 HCC 发生;沉默 Erbin 可增敏他莫昔芬治疗。

要点

  • 人 HCC 组织中 Erbin 表达显著升高,Erbin 通过灭活 ERα 信号驱动 HCC 发生。
  • ErbinΔC/ΔC 小鼠删除 PDZ 结构域后 ERα 蛋白稳定性增加,HCC 发生受抑。
  • 沉默 Erbin 可在体外和体内增敏 HCC 对他莫昔芬治疗的应答。

核心结论

  • Erbin 通过灭活 ERα 介导的抑瘤信号在调控 HCC 发生中起重要作用,提示靶向 Erbin/ERα 信号轴可作为 HCC 他莫昔芬治疗的新策略。

研究设计与样本

  • 研究采用人 HCC 样本免疫组化检测 Erbin 与 ERα 表达,结合体外与体内实验评估 Erbin 及 ERα 信号对 HCC 细胞生长的影响,并通过分子方法分析二者交互作用。
  • 观察了二乙基亚硝胺(DEN)或 DEN/CCl4 诱导的野生型 Erbin+/+ 与突变型 ErbinΔC/ΔC 小鼠 HCC 动物模型。
  • 在体外和体内评估了 Erbin 对他莫昔芬治疗 HCC 的调控效应。

主要发现

  • Erbin 通过其与 ERα 的相互作用增强 Chip 与 ERα 结合,促进 ERα 泛素化与降解,从而灭活 ERα 信号驱动 HCC 发生。
  • ErbinΔC/ΔC 小鼠删除 Erbin 的 PDZ 结构域后,Chip 与 ERα 的相互作用被破坏,ERα 蛋白稳定性增加,从而抑制 HCC 发生。
  • 沉默 Erbin 可在体外和体内有效增敏 HCC 对他莫昔芬治疗的应答。

临床怎么用

  • 作者认为靶向 Erbin/ERα 信号轴可能为 HCC 的他莫昔芬治疗提供新策略。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: Aberrant estrogen receptor-α (ERα) expression and signaling are implicated in the development of hepatocellular carcinoma (HCC), but its regulation in HCC remains enigmatic. Herein, we aimed to identify a new mechanism by which ERα signaling is regulated in HCC, which may lead to a potential new strategy for HCC therapy. METHODS: Expression levels of Erbin and ERα in human HCC samples were evaluated by immunohistochemistry. In vitro and in vivo experiments were used to assess the effect of Erbin and ERα signaling on HCC cell growth. Crosstalk between Erbin and ERα signaling was analyzed by molecular methods. Animal models of diethylnitrosamine (DEN) or DEN/CCl4-induced HCC in wild-type Erbin+/+ and mutant ErbinΔC/ΔC mice were observed. The regulatory effects of Erbin on tamoxifen treatment of HCC were evaluated in vitro and in vivo. RESULTS: Erbin inactivated ERα signaling to drive tumorigenesis of HCC, acting to enhance binding of Chip to ERα via its interaction with ERα and thereby promoting ubiquitination and degradation of ERα. Deletion of the PDZ domain of Erbin in ErbinΔC/ΔC mice, disrupted the interaction of Chip and ERα, increased the stability of ERα protein, and thus inhibited tumorigenesis of HCC. Silencing of Erbin effectively sensitized the response of HCC after tamoxifen treatment in vitro and in vivo. CONCLUSIONS: Our data uncovered an important role of Erbin in regulating HCC tumorigenesis through inactivating ERα-mediated tumor-suppressive signaling, suggesting a new strategy for tamoxifen therapy in HCC by targeting Erbin/ERα signaling axis. LAY SUMMARY: Erbin expression is significantly elevated in human hepatocellular carcinoma (HCC) tissue. This elevated expression of Erbin contributes to tumorigenesis of HCC by negatively regulating ERα signaling. However, restoring ERα signaling by inhibiting Erbin expression enhances the sensitivity of HCC cells to tamoxifen treatment, providing a new approach for tamoxifen treatment in HCC.

来源:J Hepatol,查看原文。版权归原作者所有。

引用

  1. Wu H, Yao S, Zhang S, et al. Elevated expression of Erbin destabilizes ERα protein and promotes tumorigenesis in hepatocellular carcinoma. J Hepatol. 2017. PMID: 28192186. doi:10.1016/j.jhep.2017.01.030

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。